|
Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
| 252.00 GBX | -.--% |
|
+9.09% | +5.88% |
| 02-03 | Bakkavor Group plc Appoints Andy Parton as Director, Effective January 21, 2026 | CI |
| 02-03 | Bakkavor Group plc Appoints Lee Finney as Director, Effective January 21, 2026 | CI |
| Fiscal Period: December | 2015 | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 |
|---|---|---|---|---|---|---|---|---|---|---|
Profitability | ||||||||||
Return on Assets | 3.59 | 4 | 3.2 | 3.96 | 4.82 | |||||
Return on Total Capital | 5.07 | 5.67 | 4.68 | 5.98 | 7.6 | |||||
Return On Equity % | 5.86 | 9.17 | 1.99 | 8.8 | 9.1 | |||||
Return on Common Equity | 5.86 | 9.17 | 1.99 | 8.8 | 9.1 | |||||
Margin Analysis | ||||||||||
Gross Profit Margin % | 28.66 | 28.89 | 26.3 | 26.74 | 27.71 | |||||
SG&A Margin | 24 | 23.84 | 22.66 | 22.4 | 22.7 | |||||
EBITDA Margin % | 7.74 | 7.95 | 6.31 | 6.96 | 7.38 | |||||
EBITA Margin % | 4.69 | 5.08 | 3.68 | 4.39 | 5.02 | |||||
EBIT Margin % | 4.66 | 5.05 | 3.65 | 4.35 | 5.01 | |||||
Income From Continuing Operations Margin % | 1.9 | 3.03 | 0.58 | 2.45 | 2.43 | |||||
Net Income Margin % | 1.9 | 3.03 | 0.58 | 2.45 | 2.43 | |||||
Net Avail. For Common Margin % | 1.9 | 3.03 | 0.58 | 2.45 | 2.43 | |||||
Normalized Net Income Margin | 2.36 | 2.48 | 1.71 | 1.96 | 2.45 | |||||
Levered Free Cash Flow Margin | 1.27 | 3.59 | 2.75 | 4.05 | 4.18 | |||||
Unlevered Free Cash Flow Margin | 1.94 | 4.15 | 3.34 | 4.8 | 4.87 | |||||
Asset Turnover | ||||||||||
Asset Turnover | 1.23 | 1.27 | 1.41 | 1.46 | 1.54 | |||||
Fixed Assets Turnover | 3.29 | 3.46 | 3.91 | 4.17 | 4.63 | |||||
Receivables Turnover (Average Receivables) | 16.36 | 16.35 | 17.66 | 16.44 | 15.37 | |||||
Inventory Turnover (Average Inventory) | 19.96 | 19.78 | 20.08 | 20.5 | 21.55 | |||||
Short Term Liquidity | ||||||||||
Current Ratio | 0.55 | 0.59 | 0.61 | 0.56 | 0.58 | |||||
Quick Ratio | 0.37 | 0.39 | 0.4 | 0.39 | 0.39 | |||||
Operating Cash Flow to Current Liabilities | 0.21 | 0.35 | 0.27 | 0.3 | 0.28 | |||||
Days Sales Outstanding (Average Receivables) | 22.25 | 22.27 | 21 | 22.14 | 23.68 | |||||
Days Outstanding Inventory (Average Inventory) | 18.24 | 18.41 | 18.47 | 17.76 | 16.89 | |||||
Average Days Payable Outstanding | 67.22 | 63.32 | 61.19 | 62.57 | 61.11 | |||||
Cash Conversion Cycle (Average Days) | -26.73 | -22.65 | -21.71 | -22.67 | -20.55 | |||||
Long Term Solvency | ||||||||||
Total Debt/Equity | 73.15 | 63.24 | 67.9 | 58.69 | 49.76 | |||||
Total Debt / Total Capital | 42.25 | 38.74 | 40.44 | 36.98 | 33.23 | |||||
LT Debt/Equity | 67.41 | 61.09 | 63.95 | 52.6 | 46.68 | |||||
Long-Term Debt / Total Capital | 38.93 | 37.42 | 38.09 | 33.15 | 31.17 | |||||
Total Liabilities / Total Assets | 58.73 | 57.39 | 59.92 | 58.95 | 58.89 | |||||
EBIT / Interest Expense | 4.33 | 5.59 | 3.9 | 3.62 | 4.57 | |||||
EBITDA / Interest Expense | 7.78 | 9.48 | 7.35 | 6.24 | 7.21 | |||||
(EBITDA - Capex) / Interest Expense | 4.86 | 5.94 | 4.3 | 4.72 | 5.24 | |||||
Total Debt / EBITDA | 2.91 | 2.53 | 2.85 | 2.16 | 1.69 | |||||
Net Debt / EBITDA | 2.75 | 2.34 | 2.58 | 1.92 | 1.52 | |||||
Total Debt / (EBITDA - Capex) | 4.66 | 4.04 | 4.88 | 2.85 | 2.33 | |||||
Net Debt / (EBITDA - Capex) | 4.4 | 3.73 | 4.42 | 2.55 | 2.09 | |||||
Growth Over Prior Year | ||||||||||
Total Revenues, 1 Yr. Growth % | -4.9 | 4.35 | 14.3 | 3.02 | 4.03 | |||||
Gross Profit, 1 Yr. Growth % | 0.63 | 5.17 | 4.07 | 4.74 | 7.79 | |||||
EBITDA, 1 Yr. Growth % | 0.73 | 8.38 | -9.34 | 13.81 | 10.44 | |||||
EBITA, 1 Yr. Growth % | -6.97 | 15.01 | -17.16 | 23.18 | 18.92 | |||||
EBIT, 1 Yr. Growth % | -7.01 | 15.1 | -17.46 | 22.98 | 19.83 | |||||
Earnings From Cont. Operations, 1 Yr. Growth % | -7.59 | 66.57 | -77.99 | 331.2 | 3.34 | |||||
Net Income, 1 Yr. Growth % | -7.59 | 66.57 | -77.99 | 331.2 | 3.34 | |||||
Normalized Net Income, 1 Yr. Growth % | 4.32 | 12.25 | -21.16 | 18.15 | 30.43 | |||||
Diluted EPS Before Extra, 1 Yr. Growth % | -7.94 | 65.52 | -78.12 | 338.1 | 3.26 | |||||
Accounts Receivable, 1 Yr. Growth % | 7.47 | 1.58 | 9.88 | 11.44 | 11.11 | |||||
Inventory, 1 Yr. Growth % | -0.93 | 10.97 | 21.75 | -17.29 | 15.71 | |||||
Net Property, Plant and Equip., 1 Yr. Growth % | -3.32 | 1.85 | 0.53 | -7.33 | -4.9 | |||||
Total Assets, 1 Yr. Growth % | -0.95 | 3.75 | 2.52 | -3.96 | 1.24 | |||||
Tangible Book Value, 1 Yr. Growth % | -39.12 | -79.33 | 315.32 | 20.17 | -4.15 | |||||
Common Equity, 1 Yr. Growth % | 5.73 | 7.12 | -3.57 | -1.65 | 1.4 | |||||
Cash From Operations, 1 Yr. Growth % | -22.37 | 62.71 | -11.74 | 16.21 | 1.76 | |||||
Capital Expenditures, 1 Yr. Growth % | -42.97 | 6.03 | 2.17 | -33.88 | 22.03 | |||||
Levered Free Cash Flow, 1 Yr. Growth % | 21.21 | 206.22 | -12.3 | 52.25 | 7.33 | |||||
Unlevered Free Cash Flow, 1 Yr. Growth % | 14.31 | 129.01 | -8.13 | 48.52 | 5.36 | |||||
Dividend Per Share, 1 Yr. Growth % | - | - | 5 | 5.05 | 9.89 | |||||
Compound Annual Growth Rate Over Two Years | ||||||||||
Total Revenues, 2 Yr. CAGR % | -1.73 | -0.38 | 9.21 | 8.51 | 3.53 | |||||
Gross Profit, 2 Yr. CAGR % | 2.79 | 2.88 | 4.62 | 4.41 | 6.26 | |||||
EBITDA, 2 Yr. CAGR % | -4.41 | 3.91 | -0.88 | 1.5 | 12.11 | |||||
EBITA, 2 Yr. CAGR % | -13.35 | 2.51 | -2.39 | 0.89 | 21.04 | |||||
EBIT, 2 Yr. CAGR % | -13.45 | 2.53 | -2.53 | 0.69 | 21.4 | |||||
Earnings From Cont. Operations, 2 Yr. CAGR % | -28.77 | 24.07 | -39.46 | -2.59 | 111.09 | |||||
Net Income, 2 Yr. CAGR % | -28.77 | 24.07 | -39.46 | -2.59 | 111.09 | |||||
Normalized Net Income, 2 Yr. CAGR % | -17.82 | 7.01 | -5.92 | -3.57 | 24.14 | |||||
Diluted EPS Before Extra, 2 Yr. CAGR % | -28.98 | 23.44 | -39.83 | -2.11 | 112.69 | |||||
Accounts Receivable, 2 Yr. CAGR % | 0.13 | 4.49 | 5.65 | 10.65 | 11.27 | |||||
Inventory, 2 Yr. CAGR % | 0.79 | 4.85 | 16.24 | 0.35 | -2.17 | |||||
Net Property, Plant and Equip., 2 Yr. CAGR % | 11.98 | -0.77 | 1.19 | -3.48 | -6.13 | |||||
Total Assets, 2 Yr. CAGR % | 4.29 | 1.37 | 3.13 | -0.77 | -1.4 | |||||
Tangible Book Value, 2 Yr. CAGR % | -19.95 | -64.52 | -7.35 | 123.41 | 7.32 | |||||
Common Equity, 2 Yr. CAGR % | 2.49 | 6.42 | 1.63 | -2.62 | -0.14 | |||||
Cash From Operations, 2 Yr. CAGR % | -5.5 | 12.39 | 19.84 | 1.28 | 8.74 | |||||
Capital Expenditures, 2 Yr. CAGR % | -29.26 | -22.24 | 4.08 | -17.81 | -10.17 | |||||
Levered Free Cash Flow, 2 Yr. CAGR % | 39.86 | 88.92 | 63.88 | 15.37 | 27.83 | |||||
Unlevered Free Cash Flow, 2 Yr. CAGR % | 209 | 59.6 | 45.05 | 16.76 | 25.09 | |||||
Dividend Per Share, 2 Yr. CAGR % | - | 4.88 | - | 5.03 | 7.44 | |||||
Compound Annual Growth Rate Over Three Years | ||||||||||
Total Revenues, 3 Yr. CAGR % | -0.39 | 0.26 | 4.29 | 7.11 | 7 | |||||
Gross Profit, 3 Yr. CAGR % | 1.91 | 3.58 | 3.27 | 4.66 | 5.52 | |||||
EBITDA, 3 Yr. CAGR % | -2.83 | -0.68 | -0.71 | 3.74 | 4.4 | |||||
EBITA, 3 Yr. CAGR % | -9.03 | -5.34 | -4.51 | 5.39 | 6.58 | |||||
EBIT, 3 Yr. CAGR % | -9.02 | -5.39 | -4.62 | 5.28 | 6.7 | |||||
Earnings From Cont. Operations, 3 Yr. CAGR % | 3.23 | -5.45 | -30.29 | 16.49 | -0.65 | |||||
Net Income, 3 Yr. CAGR % | 3.23 | -5.45 | -30.29 | 16.49 | -0.65 | |||||
Normalized Net Income, 3 Yr. CAGR % | -0.78 | -9.5 | -3.35 | 1.44 | 6.65 | |||||
Diluted EPS Before Extra, 3 Yr. CAGR % | 0 | -5.84 | -30.66 | 16.62 | -0.35 | |||||
Accounts Receivable, 3 Yr. CAGR % | -1.62 | 0.61 | 6.25 | 7.54 | 10.81 | |||||
Inventory, 3 Yr. CAGR % | 5.2 | 4.08 | 10.21 | 3.77 | 5.23 | |||||
Net Property, Plant and Equip., 3 Yr. CAGR % | 16.62 | 8.5 | -0.34 | -1.74 | -3.96 | |||||
Total Assets, 3 Yr. CAGR % | 5.53 | 4.11 | 1.75 | 0.71 | -0.11 | |||||
Tangible Book Value, 3 Yr. CAGR % | -27.29 | -49.02 | -19.45 | 1.04 | 68.5 | |||||
Common Equity, 3 Yr. CAGR % | 5.45 | 4.01 | 2.98 | 0.53 | -1.3 | |||||
Cash From Operations, 3 Yr. CAGR % | -1.78 | 13.27 | 3.69 | 18.62 | 1.44 | |||||
Capital Expenditures, 3 Yr. CAGR % | -10.66 | -19.04 | -14.83 | -10.53 | -6.23 | |||||
Levered Free Cash Flow, 3 Yr. CAGR % | -5.09 | 79.25 | 46.28 | 59.74 | 12.63 | |||||
Unlevered Free Cash Flow, 3 Yr. CAGR % | -3.91 | 177.1 | 32.77 | 46.15 | 12.83 | |||||
Dividend Per Share, 3 Yr. CAGR % | - | 3.23 | 4.92 | - | 6.62 | |||||
Compound Annual Growth Rate Over Five Years | ||||||||||
Total Revenues, 5 Yr. CAGR % | 1.38 | 1.2 | 3.34 | 3.48 | 3.98 | |||||
Gross Profit, 5 Yr. CAGR % | 2.25 | 2.08 | 2.99 | 3.91 | 4.45 | |||||
EBITDA, 5 Yr. CAGR % | 1.29 | 0.34 | -2.27 | 0.18 | 4.2 | |||||
EBITA, 5 Yr. CAGR % | -2.26 | -2.73 | -6.76 | -2.9 | 4.93 | |||||
EBIT, 5 Yr. CAGR % | -1.07 | -2.44 | -6.81 | -3.01 | 5.01 | |||||
Earnings From Cont. Operations, 5 Yr. CAGR % | -2.35 | 2.26 | -16.61 | -4.32 | 8.58 | |||||
Net Income, 5 Yr. CAGR % | -7.59 | 2.06 | -16.61 | -4.32 | 8.58 | |||||
Normalized Net Income, 5 Yr. CAGR % | 3.87 | -2.33 | -3.3 | -7.17 | 6.79 | |||||
Diluted EPS Before Extra, 5 Yr. CAGR % | -28.77 | 1.8 | -18.39 | -4.36 | 8.56 | |||||
Accounts Receivable, 5 Yr. CAGR % | -5.96 | -6.58 | 1.23 | 4.52 | 8.23 | |||||
Inventory, 5 Yr. CAGR % | 2.1 | 3.64 | 9.48 | 2.57 | 5.08 | |||||
Net Property, Plant and Equip., 5 Yr. CAGR % | 13.74 | 12.36 | 10.18 | 3.54 | -2.7 | |||||
Total Assets, 5 Yr. CAGR % | 2.5 | 3.76 | 4.56 | 2.13 | 0.48 | |||||
Tangible Book Value, 5 Yr. CAGR % | -28.85 | -47.42 | -19.89 | -7.94 | -9.65 | |||||
Common Equity, 5 Yr. CAGR % | 11.09 | 11.08 | 3.91 | 1.31 | 1.72 | |||||
Cash From Operations, 5 Yr. CAGR % | -3.36 | 5.14 | 6.36 | 8.31 | 5.68 | |||||
Capital Expenditures, 5 Yr. CAGR % | 8.1 | -2.34 | -5.03 | -18.55 | -13 | |||||
Levered Free Cash Flow, 5 Yr. CAGR % | -21.8 | 8.59 | 17.17 | 50.29 | 38.52 | |||||
Unlevered Free Cash Flow, 5 Yr. CAGR % | -19.74 | 3.3 | 12.68 | 96.11 | 29.62 | |||||
Dividend Per Share, 5 Yr. CAGR % | - | - | - | 3.94 | 5.92 |
- Stock Market
- Equities
- BAKK Stock
- Financials BAKVR GRP
- Financial Ratios
Select your edition
All financial news and data tailored to specific country editions
MarketScreener is also available in this country: United States.
Switch edition















